CDK2-IN-22
CDK2-IN-22 (compound 7I) is a potent CDK2 inhibitor with an IC50 of 64.42 nM. CDK2-IN-22 presents a broad antiproliferative efficacy toward diverse cancer cells MV4-11, HT-29, MCF-7, and HeLa with IC50 values of 0.83 μM, 2.12 μM, 3.12 μM, and 8.61 μM, respectively[1].
Product Specifications
UNSPSC
12352005
Target
CDK
Type
Reference compound
Related Pathways
Cell Cycle/DNA Damage
Applications
Cancer-Kinase/protease
Field of Research
Cancer
Assay Protocol
https://www.medchemexpress.com/cdk2-in-22.html
Purity
98.64
Solubility
DMSO : 250 mg/mL (ultrasonic)
Smiles
O=S(C1=CC=C(NC2=NC=CC(NC3=CC(OC4=CC=CC=C4)=CN=C3)=N2)C=C1)(N)=O
Molecular Formula
C21H18N6O3S
Molecular Weight
434.47
References & Citations
[1]Wen-Bin Zeng, et al. Design, synthesis, and biological evaluation of N- (pyridin-3-yl) pyrimidin-4-amine analogues as novel cyclin-dependent kinase 2 inhibitors for cancer therapy. Bioorg Chem. 2024 Feb:143:107019.
Shipping Conditions
Blue Ice
Storage Conditions
-20°C, 3 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Isoform
CDK2
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
HP231561 200 Reactions
ZNF720 Human qPCR Primer Pair (NM_001130913)
Sign In for Pricing
View Details 
GAF-422-40 1 mL
Colloidal Gold Conjugated Goat Affinity Purified Antibody to Cat IgG, Fc Specific, 40nm
Sign In for Pricing
View Details 
HA601391 100 µL
Apolipoprotein E Recombinant Chimeric Antibody Antibody
Sign In for Pricing
View Details 
